Armbruster Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,335
| Closed | -$473K | – | 139 |
|
|
2024
Q3 | $473K | Buy |
+16,335
| New | +$477K | 0.09% | 91 |
|
|
2023
Q4 | – | Sell |
-6,695
| Closed | -$222K | – | 103 |
|
|
2023
Q3 | $222K | Sell |
6,695
-1,520
| -19% | -$53.8K | 0.06% | 97 |
|
|
2023
Q2 | $301K | Hold |
8,215
| – | – | 0.07% | 88 |
|
|
2023
Q1 | $335K | Sell |
8,215
-550
| -6% | -$23.8K | 0.09% | 84 |
|
|
2022
Q4 | $449K | Hold |
8,765
| – | – | 0.12% | 71 |
|
|
2022
Q3 | $384K | Hold |
8,765
| – | – | 0.11% | 77 |
|
|
2022
Q2 | $460K | Hold |
8,765
| – | – | 0.12% | 72 |
|
|
2022
Q1 | $454K | Buy |
8,765
+543
| +7% | +$28.2K | 0.11% | 78 |
|
|
2021
Q4 | $486K | Buy |
8,222
+3,041
| +59% | +$151K | 0.11% | 82 |
|
|
2021
Q3 | $223K | Buy |
5,181
+66
| +1% | +$2.92K | 0.06% | 88 |
|
|
2021
Q2 | $200K | Buy |
+5,115
| New | +$199K | 0.06% | 97 |
|
|
2020
Q1 | – | Sell |
-5,449
| Closed | -$203K | – | 87 |
|
|
2019
Q4 | $203K | Buy |
+5,449
| New | +$194K | 0.08% | 79 |
|
|
2019
Q3 | – | Sell |
-5,449
| Closed | -$224K | – | 78 |
|
|
2019
Q2 | $224K | Hold |
5,449
| – | – | 0.09% | 70 |
|
|
2019
Q1 | $220K | Hold |
5,449
| – | – | 0.1% | 68 |
|
|
2018
Q4 | $226K | Sell |
5,449
-1,477
| -21% | -$61.3K | 0.11% | 61 |
|
|
2018
Q3 | $290K | Buy |
+6,926
| New | +$267K | 0.13% | 61 |
|
|
2018
Q2 | – | Sell |
-5,871
| Closed | -$198K | – | 164 |
|
|
2018
Q1 | $198K | Hold |
5,871
| – | – | 0.09% | 66 |
|
|
2017
Q4 | $202K | Hold |
5,871
| – | – | 0.09% | 67 |
|
|
2017
Q3 | $199K | Sell |
5,871
-946
| -14% | -$30.4K | 0.1% | 63 |
|
|
2017
Q2 | $217K | Buy |
6,817
+946
| +16% | +$29.8K | 0.12% | 61 |
|
|
2017
Q1 | $191K | Hold |
5,871
| – | – | 0.11% | 62 |
|
|
2016
Q4 | $181K | Hold |
5,871
| – | – | 0.11% | 68 |
|
|
2016
Q3 | $189K | Sell |
5,871
-350
| -6% | -$11.7K | 0.12% | 66 |
|
|
2016
Q2 | $208K | Sell |
6,221
-1,144
| -16% | -$36.5K | 0.13% | 64 |
|
|
2016
Q1 | $207K | Sell |
7,365
-211
| -3% | -$6.03K | 0.14% | 63 |
|
|
2015
Q4 | $232K | Buy |
+7,576
| New | +$238K | 0.21% | 58 |
|
Other funds holding PFE
Armbruster Capital Management's PFE Position: Q4 2024 in Review
Armbruster Capital Management sold out of Pfizer (PFE) in Q4 2024, closing a stake of 16,335 shares — an estimated $473K sold.
Armbruster Capital Management first reported a position in PFE in Q4 2015 and held it in 26 quarters. The position peaked at $486K in Q4 2021. 3,003 funds tracked by Wall St. Rank hold PFE as of Q4 2024.
- Armbruster Capital Management reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
- Armbruster Capital Management sold 16,335 Pfizer shares in Q4 2024, an estimated $473K.
- Armbruster Capital Management first reported a position in Pfizer in Q4 2015 and held it in 26 quarters.
- Armbruster Capital Management's Pfizer position peaked at $486K in Q4 2021.
- 3,003 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.
Based on Armbruster Capital Management's 13F filing for Q4 2024, filed 22 Jan 2025.